Cyclosporine A in psoriasis: An immunohistological study

N. Mozzanica, A. Cattaneo, P. D. Pigatto, A. F. Finzi

Research output: Contribution to journalArticlepeer-review


It is certain that CsA is a very effective drug for the treatment of psoriasis and that CsA acts preferentially on T lymphocytes. It is tempting to speculate that activated T cells play a role in the pathogenesis of psoriasis. The rapid relapse of the disease after discontinuation of CsA treatment supports the idea that activated T lymphocytes are reversibly inactivated by the drug.

Original languageEnglish
Pages (from-to)78-84
Number of pages7
JournalTransplantation Proceedings
Issue number3 SUPPL. 4
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Surgery
  • Transplantation


Dive into the research topics of 'Cyclosporine A in psoriasis: An immunohistological study'. Together they form a unique fingerprint.

Cite this